Drug Profile
Research programme: serotonin 7 receptor antagonists - GlaxoSmithKline
Alternative Names: SB 258741; SB 269970; SB 691673Latest Information Update: 18 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Piperidines; Pyrrolidines; Tosyl compounds
- Mechanism of Action Serotonin 7 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Major depressive disorder; Schizophrenia; Sleep disorders
Most Recent Events
- 05 Sep 2002 Preclinical trials in Depression in Denmark (unspecified route)
- 05 Sep 2002 Preclinical trials in Sleep disorders in Denmark (unspecified route)